Literature DB >> 20514455

Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells.

Ya-Yin Chen1, Jing-Gung Chung, Hsiu-Ching Wu, Da-Tian Bau, Kuen-Yuh Wu, Shung-Te Kao, Chien-Yun Hsiang, Tin-Yun Ho, Su-Yin Chiang.   

Abstract

Aristolochic acid (AA), derived from plants of the Aristolochia genus, has been proven to be associated with aristolochic acid nephropathy (AAN) and urothelial cancer in AAN patients. In this study, we used toxicogenomic analysis to clarify the molecular mechanism of AA-induced cytotoxicity in normal human kidney proximal tubular (HK-2) cells, the target cells of AA. AA induced cytotoxic effects in a dose-dependent (10, 30, 90 microM for 24 h) and time-dependent manner (30 microM for 1, 3, 6, 12 and 24 h). The cells from those experiments were then used for microarray experiments in triplicate. Among the differentially expressed genes analyzed by Limma and Ingenuity Pathway Analysis software, we found that genes in DNA repair processes were the most significantly regulated by all AA treatments. Furthermore, response to DNA damage stimulus, apoptosis, and regulation of cell cycle, were also significantly regulated by AA treatment. Among the differentially expressed genes found in the dose-response and time-course studies that were involved in these biological processes, two up-regulated (GADD45B, NAIP), and six down-regulated genes (TP53, PARP1, OGG1, ERCC1, ERCC2, and MGMT) were con-firmed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). AA exposure also caused a down-regulation of the gene expression of anti-oxidant enzymes, such as superoxide dismutase, glutathione reductase, and glutathione peroxidase. Moreover, AA treatment led to increased frequency of DNA strand breaks, 8-hydroxydeoxyguanosine-positive nuclei, and micronuclei in a dose-dependent manner in HK-2 cells, possibly as a result of the inhibition of DNA repair. These data suggest that oxidative stress plays a role in the cytotoxicity of AA. In addition, our results provide insight into the involvement of down-regulation of DNA repair gene expression as a possible mechanism for AA-induced genotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514455     DOI: 10.3892/or_00000839

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Authors:  Katsuomi Matsui; Atsuko Kamijo-Ikemorif; Takeshi Sugaya; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 2.  Aristolochic acid-associated cancers: a public health risk in need of global action.

Authors:  Samrat Das; Shefali Thakur; Michael Korenjak; Viktoriya S Sidorenko; Felicia Fei-Lei Chung; Jiri Zavadil
Journal:  Nat Rev Cancer       Date:  2022-07-19       Impact factor: 69.800

3.  Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair.

Authors:  Navin Gupta; Takuya Matsumoto; Ken Hiratsuka; Edgar Garcia Saiz; Pierre Galichon; Tomoya Miyoshi; Koichiro Susa; Narihito Tatsumoto; Michifumi Yamashita; Ryuji Morizane
Journal:  Sci Transl Med       Date:  2022-03-02       Impact factor: 19.319

4.  A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets.

Authors:  D E Marin; G C Pistol; M Gras; M Palade; I Taranu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-22       Impact factor: 3.000

Review 5.  Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition.

Authors:  Thomas Baudoux; Inès Jadot; Anne-Emilie Declèves; Marie-Hélène Antoine; Jean-Marie Colet; Olivia Botton; Eric De Prez; Agnieszka Pozdzik; Cécile Husson; Nathalie Caron; Joëlle L Nortier
Journal:  Front Med (Lausanne)       Date:  2022-05-04

Review 6.  Chemical Constituents and Pharmacology of the Aristolochia ( mădōu ling) species.

Authors:  Ping-Chung Kuo; Yue-Chiun Li; Tian-Shung Wu
Journal:  J Tradit Complement Med       Date:  2012-10

7.  Prediction and Characterisation of the System Effects of Aristolochic Acid: A Novel Joint Network Analysis towards Therapeutic and Toxicological Mechanisms.

Authors:  Wenna Nie; Yana Lv; Leyu Yan; Xi Chen; Haitao Lv
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

8.  Bioinformatics facilitating the use of microarrays to delineate potential miRNA biomarkers in aristolochic acid nephropathy.

Authors:  Yana Lv; Yumei Que; Qiao Su; Qiang Li; Xi Chen; Haitao Lu
Journal:  Oncotarget       Date:  2016-08-09

9.  Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks.

Authors:  Yin-Ying Wang; Zhiguang Li; Tao Chen; Xing-Ming Zhao
Journal:  IET Syst Biol       Date:  2015-08       Impact factor: 1.615

10.  Combination of extracts from Aristolochia cymbifera with streptomycin as a potential antibacterial drug.

Authors:  Willer F Silva; Samyra G Cecílio; Cintia Lb Magalhães; Jaqueline Ms Ferreira; Antonio H Tótola; Jose C de Magalhaes
Journal:  Springerplus       Date:  2013-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.